Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of Kaloba (EPs 7630) tablets in adults with common cold
ISRCTN65790556Phase 4Completed
- Sponsor
- Schwabe Group
- Start
- Jan 2011
01
Overview
Phase 4, open-label, single-arm trial of pelargonium sidoides extract in nasopharyngitis, sponsored by Schwabe Group. Primary endpoints: Adverse events surveillance, Treatment outcome by IMOS and 9 more. Started Jan 2011; status: completed.
02
Drugs
pelargonium sidoides extract
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ISRCTN65790556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65790556.